Aptevo Therapeutics: Surges after cancer symptoms disappear in study patient

Aptevo Therapeutics

03/11/2020 16:55

** Drug developer's shares  APVO.O  surge 17.8% to $7.42, their
highest in nearly a month
    ** APVO says a patient in its early stage trial of its drug
candidate APVO436 for the treatment of acute myeloid leukemia
(AML) and another type of blood cancer has shown complete
remission or disappearance of symptoms  urn:newsml:reuters.com:*:nACSCDJGqa
    ** Says patient's bone marrow blasts or immature white blood
cells decreased from 29% to 6% after the first cycle of
treatment and to 0% after the second cycle 
    ** More than 10.2 mln shares being traded vs 25-day moving
avg of 22,656
    ** Up to Monday's close, stock down 31.3% YTD

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))